Year-End Report

DALRYMPLE & ASSOCIATES, LLC for EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$100,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
Year-End Report (this page) Jan 23, 2008 $100,000 Replaced
Year-End Report Jan 30, 2008 $100,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Defense authorization and appropriations legislation, MILVAX Program, Biodefense and biological product acquisition and R&D issues

LobbyistCovered position, as disclosed
DONALD DALRYMPLE PRINCIPAL

Contacted: Defense, Dept of (DOD); White House Office; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS)

Health Issues HCR

Project BioShield, Biodefense vaccine and biological product R&D, procurement for the Strategic National Stockpile, and product liability related oversight, authorizing, and appropriations legislation; DHHS and CDC procurement of anthrax vaccines

LobbyistCovered position, as disclosed
DONALD DALRYMPLE PRINCIPAL

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Defense, Dept of (DOD); SENATE; White House Office; Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS)

Homeland Security HOM

Project BioShield and bioterrorism preparedness authorization and appropriatons legislation and related oversight issues

LobbyistCovered position, as disclosed
DONALD DALRYMPLE PRINCIPAL

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); White House Office; Centers For Disease Control & Prevention (CDC); Defense, Dept of (DOD)

Medical/Disease Research/Clinical Labs MED

Biodefense R&D Vaccine and Biological Product funding

LobbyistCovered position, as disclosed
DONALD DALRYMPLE PRINCIPAL

Contacted: White House Office; Food & Drug Administration (FDA); Homeland Security, Dept of (DHS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.